- Home
- JSPR vs EDD Comparison
JSPR vs EDD Comparison
Compare JSPR & EDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JSPR
- EDD
- Stock Information
- Founded
- JSPR 2018
- EDD 2007
- Country
- JSPR United States
- EDD United States
- Employees
- JSPR N/A
- EDD N/A
- Industry
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- EDD Finance Companies
- Sector
- JSPR Health Care
- EDD Finance
- Exchange
- JSPR Nasdaq
- EDD Nasdaq
- Market Cap
- JSPR 342.2M
- EDD 304.3M
- IPO Year
- JSPR N/A
- EDD N/A
- Fundamental
- Price
- JSPR $21.53
- EDD $4.71
- Analyst Decision
- JSPR Strong Buy
- EDD
- Analyst Count
- JSPR 10
- EDD 0
- Target Price
- JSPR $74.86
- EDD N/A
- AVG Volume (30 Days)
- JSPR 210.0K
- EDD 254.3K
- Earning Date
- JSPR 11-07-2024
- EDD 01-01-0001
- Dividend Yield
- JSPR N/A
- EDD 7.52%
- EPS Growth
- JSPR N/A
- EDD N/A
- EPS
- JSPR N/A
- EDD N/A
- Revenue
- JSPR N/A
- EDD N/A
- Revenue This Year
- JSPR N/A
- EDD N/A
- Revenue Next Year
- JSPR N/A
- EDD N/A
- P/E Ratio
- JSPR N/A
- EDD N/A
- Revenue Growth
- JSPR N/A
- EDD N/A
- 52 Week Low
- JSPR $4.00
- EDD $4.22
- 52 Week High
- JSPR $31.01
- EDD $4.95
- Technical
- Relative Strength Index (RSI)
- JSPR 47.34
- EDD 50.65
- Support Level
- JSPR $22.30
- EDD $4.61
- Resistance Level
- JSPR $26.05
- EDD $4.75
- Average True Range (ATR)
- JSPR 1.67
- EDD 0.05
- MACD
- JSPR -0.08
- EDD 0.02
- Stochastic Oscillator
- JSPR 34.78
- EDD 73.33
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
About EDD Morgan Stanley Emerging Markets Domestic Debt Fund Inc.
Morgan Stanley Emerging Markets Domestic Debt Fund Inc is a closed-end management investment company. The company's primary investment objective is to seek a high level of current income, with a secondary investment objective of long-term capital appreciation. It seeks to achieve investment objectives by investing, under normal circumstances, at least 80% of its managed assets in emerging markets domestic debt. The fund's portfolio includes sovereign, quasi-sovereign, corporate bonds in emerging markets.